Biomarkers of ovarian reserve as predictors of reproductive potential

Seminars in Reproductive Medicine

Volumn 31, Issue 6, 2013, Pages 437-442

  Steiner, Anne Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

biomarkers; fertility; ovarian reserve

Indexed keywords

FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; BIOLOGICAL MARKER;

AGE; ARTICLE; ARTIFICIAL INSEMINATION; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; MENSTRUAL CYCLE; OVARIAN RESERVE; PREDICTIVE VALUE; REPRODUCTIVE HEALTH; ADULT; FERTILITY; INFERTILITY, FEMALE; METABOLISM; OOCYTE DEVELOPMENT; OVARY; PATHOPHYSIOLOGY; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; BIOLOGICAL MARKERS; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; OOGENESIS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84885335927     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1356479     Document Type: Article

References (44)

1. Hansen K. R., Craig L. B., Zavy M. T., Klein N. A., Soules M. R. Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system. Menopause: 2012; 19 2 164 171
2. Faddy M. J., Gosden R. G., Gougeon A., Richardson S. J., Nelson J. F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod: 1992; 7 10 1342 1346 (Pubitemid 23042150)
3. Gracia C. R., Sammel M. D., Freeman E. W., et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause: 2005; 12 2 128 135 (Pubitemid 40464279)
4. Randolph J. F. Jr, Sowers M., Bondarenko I. V., Harlow S. D., Luborsky J. L., Little R. J. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab: 2004; 89 4 1555 1561 (Pubitemid 38507902)
5. Gnoth C., Schuring A. N., Friol K., Tigges J., Mallmann P., Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod: 2008; 23 6 1359 1365 (Pubitemid 351770586)
6. Broer S. L., van Disseldorp J., Broeze K. A., et al. IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update: 2013; 19 1 26 36
7. van Rooij I. A., Broekmans F. J., te Velde E. R., et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod: 2002; 17 12 3065 3071 (Pubitemid 35469254)
8. Tremellen K. P., Kolo M., Gilmore A., Lekamge D. N. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol: 2005; 45 1 20 24 (Pubitemid 40424710)
9. Hansen K. R., Knowlton N. S., Thyer A. C., Charleston J. S., Soules M. R., Klein N. A. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod: 2008; 23 3 699 708 (Pubitemid 351651214)
10. van Rooij I. A., Broekmans F. J., Scheffer G. J., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril: 2005; 83 4 979 987
11. Rosen M. P., Johnstone E., McCulloch C. E., et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril: 2012; 97 1 238 243
12. Gold E. B., Bromberger J., Crawford S., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol: 2001; 153 9 865 874 (Pubitemid 32378620)
13. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology 2010 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta Department of Health and Human Services: 2012
14. La Marca A., Nelson S. M., Sighinolfi G., et al. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online: 2011; 22 4 341 349 (Reproductive Healthcare Limited)
15. Jayaprakasan K., Campbell B., Hopkisson J., Johnson I., Raine-Fenning N. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril: 2010; 93 3 855 864
16. Creus M., Peñarrubia J., Fábregues F., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod: 2000; 15 11 2341 2346
17. Schwartz D., Mayaux M. J. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med: 1982; 306 7 404 406 (Pubitemid 12168296)
18. Gnoth C., Godehardt D., Godehardt E., Frank-Herrmann P., Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod: 2003; 18 9 1959 1966 (Pubitemid 37107576)
19. Abma J. C., Chandra A., Mosher W. D., Peterson L. S., Piccinino L. J. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 23: 1997; 23 19 1 114
20. Rothman K. J., Wise L. A., Sorensen H. T., Riis A. H., Mikkelsen E. M., Hatch E. E. Volitional determinants and age-related decline in fecundability: a general population prospective cohort study in Denmark. Fertil Steril: 2013; 99 7 1958 1964
21. Wise L. A., Mikkelsen E. M., Rothman K. J., et al. A prospective cohort study of menstrual characteristics and time to pregnancy. Am J Epidemiol: 2011; 174 6 701 709
22. van der Steeg J. W., Steures P., Eijkemans M. J., et al. Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab: 2007; 92 6 2163 2168 (Pubitemid 46997116)
23. Brodin T., Bergh T., Berglund L., Hadziosmanovic N., Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril: 2008; 90 5 1656 1661
24. Fiçicioǧlu C., Kutlu T., Demirbaşoǧlu S., Mulayim B. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol: 2003; 17 4 287 293 (Pubitemid 37083034)
25. Eldar-Geva T., Margalioth E. J., Ben-Chetrit A., et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod: 2002; 17 9 2331 2337 (Pubitemid 35021455)
26. Hall J. E., Welt C. K., Cramer D. W. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod: 1999; 14 2 409 415 (Pubitemid 29097396)
27. Seifer D. B., Scott R. T. Jr, Bergh P. A., et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril: 1999; 72 1 63 65 (Pubitemid 29300262)
28. Haadsma M. L., Groen H., Fidler V., et al. The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women. Hum Reprod: 2008; 23 8 1800 1807 (Pubitemid 352020023)
29. Steiner A. Z., Herring A. H., Kesner J. S., et al. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol: 2011; 117 4 798 804
30. Jain T., Soules M. R., Collins J. A. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril: 2004; 82 1 180 185 (Pubitemid 38968796)
31. Steiner A. Z., Long D. L., Herring A. H., Kesner J. S., Meadows J. W., Baird D. D. Urinary follicle-stimulating hormone as a measure of natural fertility in a community cohort. Reprod Sci: 2013; 20 5 549 556
32. McDade T. W., Woodruff T. K., Huang Y. Y., et al. Quantification of anti-Müllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve. Hum Reprod: 2012; 27 8 2503 2508
33. Lee T-H, Liu C. H., Huang C. C., Hsieh K. C., Lin P. M., Lee M. S. Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reprod Biol Endocrinol: 2009; 7 1 100
34. Lukaszuk K., Kunicki M., Liss J., Lukaszuk M., Jakiel G. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol: 2013; 168 2 173 177
35. Brodin T., Hadziosmanovic N., Berglund L., Olovsson M., Holte J. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab: 2013; 98 3 1107 1114
36. Kunt C., Ozaksit G., Keskin Kurt R., et al. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet: 2011; 283 6 1415 1421
37. Kwee J., Schats R., McDonnell J., Themmen A., de Jong F., Lambalk C. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril: 2008; 90 3 737 743
38. Hagen C. P., Vestergaard S., Juul A., et al. Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. Fertil Steril: 2012; 98 6 1602 1608, e2
39. van Disseldorp J., Lambalk C. B., Kwee J., et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod: 2010; 25 1 221 227
40. Peñarrubia J., Fábregues F., Manau D., et al. Initial analysis of variability among basal hormone biomarkers of ovarian reserve. Reprod Biomed Online: 2004; 8 2 191 195 (Pubitemid 38208466)
41. Jain T., Klein N. A., Lee D. M., Sluss P. M., Soules M. R. Endocrine assessment of relative reproductive age in normal eumenorrheic younger and older women across multiple cycles. Am J Obstet Gynecol: 2003; 189 4 1080 1084 (Pubitemid 37373902)
42. Buyalos R. P., Ghosh K., Daneshmand S. T. Infertile women of advanced reproductive age. Variability of day 3 FSH and E2 levels. J Reprod Med: 1998; 43 12 1023 1026 (Pubitemid 29016391)
43. Scott R. T. Jr, Hofmann G. E., Oehninger S., Muasher S. J. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril: 1990; 54 2 297 302 (Pubitemid 20256240)
44. Abdalla H., Thum M. Y. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH. Hum Reprod: 2006; 21 1 171 174 (Pubitemid 41794307)